ACCESSING HORMONE THERAPY
ABROAD THROUGH CANCERFAX
For patients facing unaffordable hormone therapy costs at home, CancerFax provides a structured pathway to quality drugs, specialist consultation, and monitoring coordination in India and China.
analyticsAt a Glance
- check_circleHormone therapy costs in India are 90โ98% lower than USA branded pricing for equivalent drugs
- check_circleCancerFax coordinates prescribing, quality-verified pharmacy supply, and home-country monitoring support
- check_circleProcess typically takes 5โ10 days from first contact to confirmed access plan
- check_circleMost patients do not need to travel โ drugs can be obtained during a planned visit with proper documentation
Why Patients Seek Hormone Therapy Access Abroad
The primary driver is cost โ but lack of drug availability, insurance exclusions, and the need for specialist oncology review also bring patients to CancerFax for hormone therapy navigation.
Cost โ The Primary Driver
Palbociclib at $12,000โ14,000/month in the USA costs $500โ900/month in India. Enzalutamide at $8,000โ10,000/month in the USA costs $400โ800/month in India. For patients without adequate insurance, this difference is life-changing.
Access and Availability
Some drugs approved in India or China are not yet available or approved in the patient's home country. Newer CDK4/6 inhibitors, SERD therapies, and next-generation AR antagonists become accessible months or years earlier through Indian access routes.
The CancerFax Hormone Therapy Access Process
CancerFax manages the full process from clinical review to ongoing monitoring โ patients need only follow the steps below.
- 1
Submit Your Medical Records
Upload your current pathology (receptor status, molecular markers), treatment history, and current oncologist's prescription or recommendation to CancerFax.
- 2
Clinical Review and Drug Identification
CancerFax reviews the case to confirm the appropriate hormone therapy, dose, and any monitoring requirements. The clinical team also confirms whether the drug is available as a generic in India at significant cost savings.
- 3
Specialist Consultation Coordination (if needed)
For complex cases โ ESR1 mutations, CDK4/6 inhibitor toxicity, next-generation AR antagonist selection โ CancerFax coordinates a specialist teleconsultation with an Indian or Chinese oncologist.
- 4
Prescribing and Pharmacy Coordination
CancerFax provides a referral to an Indian oncologist who issues a valid prescription. CancerFax connects patients with a quality-verified licensed pharmacy partner for drug supply.
- 5
Monitoring Coordination
CancerFax provides the monitoring schedule (which tests, how often), advises on where to get them done locally, and coordinates result review by the treating oncologist with dose adjustment recommendations.
What CancerFax Provides vs Patient Responsibility
Clear expectations from the start prevent misunderstandings about scope.
CancerFax Provides
- Clinical case review and drug confirmationCancerFax verifies the clinical indication, confirms the most appropriate generic, and flags any safety considerations before proceeding.
- Specialist oncologist coordinationConnecting patients with Indian or Chinese oncologists for prescription, consultation, and ongoing management as needed.
- Quality-verified pharmacy networkCancerFax only works with licensed Indian pharmacies stocking WHO-prequalified or USFDA-registered generic manufacturers.
Patient Responsibility
- Drug costs and pharmacy paymentsAll drug costs are paid directly to the pharmacy โ CancerFax does not handle drug procurement funds.
- Monitoring tests in home countryBlood tests, DEXA scanning, and ECGs are arranged and paid for by the patient locally โ CancerFax provides the schedule and coordinates result review.
- Home-country oncologist engagementCancerFax strongly recommends informing the home-country oncologist of all medications โ CancerFax cannot replace the local treating physician.
Frequently Asked Questions
Access Process Practicalities
Do I need to travel to India to access hormone therapy through CancerFax?
Travel is not required for the initial access process. CancerFax can coordinate teleconsultation, electronic prescription, and pharmacy supply for most hormone therapy drugs without a visit to India. For patients who do visit India for treatment (e.g. surgery or a second opinion), obtaining a multi-month drug supply during the visit is highly practical.
How is CancerFax paid for this service?
CancerFax charges a case management fee for coordination services โ separate from the drug costs, which are paid directly to the pharmacy. The fee structure is discussed and agreed before any commitments are made. For most patients, the savings on drug costs far exceed the coordination fee within the first month.
What happens if my drug needs change during treatment?
CancerFax maintains ongoing coordination for active cases. If your oncologist changes your regimen โ adds a CDK4/6 inhibitor, switches AIs, escalates to fulvestrant โ CancerFax updates the access plan accordingly, coordinating the new prescription and pharmacy supply.
More from the Hormone Therapy Resource Library
Explore cost guides, drug comparisons, and monitoring protocols.
- โ Hormone Therapy for Cancer โ Complete Guide
- Cost of Hormone Therapy Drugs: India and China vs USA
- Generic Hormone Therapy Drugs in India and China: Quality Guide
- Monitoring During Hormone Therapy: Bone Density, PSA, and Tests
- How CancerFax Helps International Cancer Patients
- Prepare Medical Reports for Treatment Abroad
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Start the Hormone Therapy Access Process with CancerFax
CancerFax reviews your case, identifies the most appropriate access route, and manages the complete process โ from specialist consultation to quality-verified drug supply and monitoring coordination.
This content is for informational purposes only. Always consult your oncologist before changing hormone therapy sources or regimens.